Scientists from Abbvie Deutschland GmbH & Co. KG and Abbvie Inc. have identified radiolabeled compounds capable of imaging and targeting microtubule-associated protein Tau (PHF-tau; MAPT) aggregates ...
Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can detect signature features of progressive supranuclear palsy (PSP), a rare ...
Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells that ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted fast track designation to a radioactive fluorinated positron emission tomography tracer for ...
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share overlapping ...
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder ...
Civil rights leader Jesse Jackson died at the age of 84 after a long battle with a rare neurological disorder. Jackson suffered from progressive supranuclear palsy, which affects movement, balance, ...
Attention has turned to progressive supranuclear palsy, a rare neurodegenerative disorder. Here's what it is and why it's often mistaken for Parkinson’s disease.
The late former presidential candidate and reverend died three months after he was hospitalized for his rare neurological condition. The late Reverend Jesse Jackson, known for his civil rights ...
Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can detect signature features of progressive supranuclear palsy (PSP), a rare ...
In the future, movement disorder specialists are likely to develop and validate clinical diagnostic criteria for CBD and a clinical rating scale instrument using objective parameters of apraxia, eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results